Retraction notice.

IF 4.6 3区医学 Q2 ENDOCRINOLOGY & METABOLISM Therapeutic Advances in Endocrinology and Metabolism Pub Date : 2022-07-12 eCollection Date: 2022-01-01 DOI:10.1177/20420188221109732

引用次数: 0

Abstract

[This retracts the article DOI: 10.1177/2042018820923474.].

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

收回通知。

[本文撤回文章DOI: 10.1177/2042018820923474.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Therapeutic Advances in Endocrinology and Metabolism Medicine-Endocrinology, Diabetes and Metabolism

CiteScore

7.70

自引率

2.60%

发文量

审稿时长

8 weeks

期刊介绍： Therapeutic Advances in Endocrinology and Metabolism delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of endocrinology and metabolism.

期刊最新文献

When HbA1c looks "too high": two practical clarifications for endocrine screening in chelated β-thalassemia major. Impacts of insulin storage and injection techniques intervention on glycemic control among patients with diabetes in northwest Ethiopia: a quasi-experimental study. Diabetes management using a clinical guideline versus usual practice: a feasibility trial-based qualitative study among Ayurvedic practitioners and patients in Nepal. Clinical significance of meteorin-like protein in type 2 diabetes mellitus and its association with carotid plaque complications. Real-world experience with teplizumab in stage 2 type 1 diabetes: a plain language summary.